a Mean creatinine after 10 years of follow-up. b Median creatinine after median 24 months of follow-up. NR, not reported. Nephron-sparing surgery (NSS) for renal cell carcinoma has the advantage of ...

Enhanced recovery after surgery (ERAS) is a set of perioperative interventions to alleviate patients' stress response and complications, and to promote rehabilitation. Data on its implementation in ...

AKI patients may play a new role in expanding the kidney donor pool. The risk of negative renal outcomes, including CKD upgrading, increases along with duration of acute kidney injury following ...

PN and RFA offer similar survival for cT1a RCC tumors ≤2 cm, but PN is superior for larger tumors. RFA may be considered for elderly patients with comorbidities, especially for tumors ≤2 cm. PN ...

More than 60% of renal cell carcinomas are now detected incidentally. Such tumors are smaller than those found based on symptomatology, less likely to metastasize, and often amenable to ...

Immune checkpoint inhibitors in the peri-operative setting in renal cell carcinoma: A meta-analysis of the randomized clinical trials. Cabozantinib in combination with atezolizumab in non-clear cell ...

Partial nephrectomy remains the optimal treatment for the management of small renal masses (SRMs), but several focal ablative techniques also exist, of which radiofrequency ablation and cryoablation ...

In patients with clinical stage 1 (cT1) renal masses, many physicians opt for nephron-sparing surgery, such as partial nephrectomy (PN) versus radical nephrectomy (RN). Both procedures have been shown ...

Current evidence on laparoscopic partial nephrectomy suggests that it is safe and efficacious when undertaken by surgeons with special expertise in this technique. Surgeons undertaking laparoscopic ...

Absolute indications include circumstances in which RN would render the patient anephric, with a consequent immediate need for renal replacement therapy. Patients with an anatomically or functionally ...